http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8401490-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1caf796feb1c8df468ef1882e65b6343
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N3-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-44
filingDate 1983-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c202ff13750987bb79d6040d61ce4a6
publicationDate 1984-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-8401490-A1
titleOfInvention Biological agents of increased efficacy
abstract Method for rendering normally insoluble biologically active materials, such as the substituted guanidine compounds soluble in plant tissue by combining said active material with a metal chelate. The method allows the active material to be formulated for liquid or granule application. The compounds proposed by the invention comprise the active material combined with a metal chelate, preferably Copper E.D.T.A. and one preferred compound comprises the 2 - Guanidinododecane acetate combined with Copper E.D.T.A.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10149919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9980479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7078566-B2
priorityDate 1982-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1476729-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2335153-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1476728-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1445074-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236271361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236271356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54074380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128601402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227191193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226445619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85856171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128065492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227315780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129589049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135926484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129243235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54308192
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127517317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57091896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411239

Total number of triples: 48.